116 related articles for article (PubMed ID: 8918008)
1. Value of acid phosphatase in screening for carcinoma in patients with prostatism in Nigeria.
Anyanwu SN
East Afr Med J; 1996 Jul; 73(7):457-8. PubMed ID: 8918008
[TBL] [Abstract][Full Text] [Related]
2. The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
Moul JW; Connelly RR; Perahia B; McLeod DG
J Urol; 1998 Mar; 159(3):935-40. PubMed ID: 9474187
[TBL] [Abstract][Full Text] [Related]
3. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population?
Anast JW; Andriole GL; Bismar TA; Yan Y; Humphrey PA
Urology; 2004 Sep; 64(3):544-50. PubMed ID: 15351590
[TBL] [Abstract][Full Text] [Related]
4. Prostatic carcinoma--1968.
Prout GR; Moncure CW
Proc Natl Cancer Conf; 1970; 6():195-209. PubMed ID: 5458093
[No Abstract] [Full Text] [Related]
5. [Diagnosis and therapy of prostatic carcinoma].
Vahlensieck W; Tümmers H; Tschischak D
Fortschr Med; 1974 Oct; 92(30):1195-8. PubMed ID: 4138473
[No Abstract] [Full Text] [Related]
6. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?
Rubin MA; Mucci NR; Manley S; Sanda M; Cushenberry E; Strawderman M; Montie JE; Bassily NH
J Urol; 2001 Jan; 165(1):114-8. PubMed ID: 11125378
[TBL] [Abstract][Full Text] [Related]
7. The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
Bruce AW; Mahan DE; Belville WD
Urol Clin North Am; 1980 Oct; 7(3):645-52. PubMed ID: 7456177
[TBL] [Abstract][Full Text] [Related]
8. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
9. [Changes in acid phosphatase levels during various prostatic operations].
Vitsou-Georgallis H; Goulandris N; Marketos N; Dimopoulos C
Acta Urol Belg; 1980 Oct; 48(4):488-97. PubMed ID: 6161530
[No Abstract] [Full Text] [Related]
10. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
[TBL] [Abstract][Full Text] [Related]
11. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
Dargent-Molina P; Douchin MN; Cormier C; Meunier PJ; Bréart G;
Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
[TBL] [Abstract][Full Text] [Related]
12. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
[TBL] [Abstract][Full Text] [Related]
13. Role of free to total prostate specific antigen ratio in serum in the diagnosis of prostatic enlargement.
Bhuiyan AK; Kibria SA; Subhan SS
Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):51-9. PubMed ID: 15813483
[TBL] [Abstract][Full Text] [Related]
14. Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.
Southwick PC; Catalona WJ; Partin AW; Slawin KM; Brawer MK; Flanigan RC; Patel A; Richie JP; Walsh PC; Scardino PT; Lange PH; Gasior GH; Parson RE; Loveland KG
J Urol; 1999 Oct; 162(4):1346-51. PubMed ID: 10492194
[TBL] [Abstract][Full Text] [Related]
15. The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan.
Egawa S; Soh S; Ohori M; Uchida T; Gohji K; Fujii A; Kuwao S; Koshiba K
Cancer; 1997 Jan; 79(1):90-8. PubMed ID: 8988731
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic significance of alkaline and acid phosphatase levels in the hormonal treatment of patients with prostatic carcinoma].
Mulders PF; Debruyne FM
Ned Tijdschr Geneeskd; 1987 Aug; 131(32):1399-402. PubMed ID: 3658014
[No Abstract] [Full Text] [Related]
17. Potentially advanced malignancies detected by screening for prostate carcinoma after an interval of 4 years.
Postma R; Roobol M; Schröder FH; van der Kwast TH
Cancer; 2004 Mar; 100(5):968-75. PubMed ID: 14983492
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer screening using fine-needle aspiration cytology prior to open prostatectomy.
Palmer LS; Laor E; Skinner WK; Tolia BM; Reid RE; Freed SZ
Eur Urol; 1995; 27(2):96-8. PubMed ID: 7744165
[TBL] [Abstract][Full Text] [Related]
19. Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins?
Tsuboi T; Ohori M; Kuroiwa K; Reuter VE; Kattan MW; Eastham JA; Scardino PT
Urology; 2005 Dec; 66(6):1287-91. PubMed ID: 16360458
[TBL] [Abstract][Full Text] [Related]
20. [Columbia University experience of detection of circulating cells by RT-PCR PSA in prostate cancer as a predictive factor of stage and biochemical recurrence].
de la Taille A; Olsson CA; Buttyan R; Bagiella E; Cao Y; Burchardt T; Katz AE
Prog Urol; 1999 Jun; 9(3):555-61. PubMed ID: 10434336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
